Inhalon Biopharma's inhaled RSV antibody treatment will enter human trials marking a potential breakthrough in respiratory ...

Respiratory Inhalers market Insights: Increased prevalence of respiratory disorders drives demand for innovative inhaler solutions. US, NY, UNITED STATES, January 23, 2025 /EINPresswire ...

Respiratory health is a critical aspect of overall wellness that often gets overlooked until issues arise. Many individuals ...

Breathing is essential for life, yet for many individuals suffering from chronic respiratory issues such as asthma and COPD, ...

Respiratory Inhalers Market is estimated to valued at USD 33.11 Bn in 2024 and expected to reach USD 49.10 Bn by 2031, exhibiting CAGR of 5.8% from 2024-2031 BURLINGAME, CA, UNITED STATES ...

Green: These inhalers tend to be for long-acting beta-agonist preventer medication, most often used to help reduce symptoms of respiratory conditions like asthma or COPD. These must also be taken ...

In a bid to improve the pharma sector’s drive to cut down greenhouse emissions, several companies are advancing dry powder inhalers (DPIs) for respiratory conditions that are more eco-friendly ...

Conventionally, inhaled drugs have been used to deliver medicines targeted at the most widespread respiratory diseases – specifically, chronic obstructive pulmonary disease (COPD) and asthma.

In a world where respiratory issues are increasingly common, finding practical solutions can be daunting. Breathe Drops ...

More than half of patients are unsure when their asthma inhaler is empty, with some continuing to use the device, research found.